Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

The Type of Leprosy Based on the Characteristics of Lepers in West Papua Province and North Maluku Province; Comparative Studies

Suebu M, Imaniar C, Wahyuni T, et al. Ikatan Ahli Kesehatan Masyarakat Indonesia (IAKMI). IAKMI Public Health Journal Indonesia. 2020; 1 (1) : 33-36.
Download PDF
Publication

Pure Neuritic Leprosy with Ichthyosis like features-A Case Report

K DP, Srinivasa M. Valley International. Journal of Medical Science And clinical Research. 2020; 08 (06) : 89-93.
Download PDF
Publication

Type-II Lepra Reaction and Granulomatous Uveitis – An Unusual Presentation

Das S. EMED Publishing. Delhi Journal of Ophthalmology. 2020; 30 (3) : 63-66.
Publication

Dermoscopy of Type 1 Lepra Reaction in Skin of Color

Jha AK, Zeeshan M, Tiwary P, et al. Dermatol Pract Concept. 2020;
Download PDF
Publication

The Correlation of Semmes-Weinstein Monofilament Test with the Level of P-75 Neurotrophin as Marker of Nerve Damage in Leprosy.

Widasmara D, Panjarwanto DA, Sananta P. Clinical, cosmetic and investigational dermatology. 2020;
Download PDF
Publication

Genomic Characterization of to Explore Transmission Patterns Identifies New Subtype in Bangladesh.

Tió-Coma M, Avanzi C, Verhard E, et al. Frontiers in microbiology. 2020;
Download PDF
Publication

The experience of persons with disabilities with COVID-19

Stakeholder Group of Persons with Disabilities . 2020;
Download PDF
Publication

A Study on Ocular Leprosy among patients attending a tertiary care centre of West Bengal

Ray S, Chaudhuri PR, Bandyopadhyay M, et al. Bengal Ophthalmic Journal. 2019;
Download PDF
Publication

Logotherapy towards self-esteem of leprosy patients at Tadjuddin Chalid Hospital in Makassar City.

Ningsi N, Zulkifli A, Mallongi A, et al. Enfermeria clinica. 2020;
Publication

Analysis of Serum Vitamin D Level in Leprosy Patients

Darus NIM, Lubis RD, Jusuf NK. Bali Medical Journal. 2020; 8 (3) : 795-799.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 125
  • Next page ››
Subscribe to South-East Asia Region (SEAR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD